Latest Tables of Contents with Summaries

2021 Том 5, №2
Echographic signs of pulmonary outcomes in patients after coronavirus infection (SARS-COV2) and difficulties of their interpretation
N.V. Klimovich, L.V. Sivachenco, O.M. Zherco, Y.L. Gorbich, O.Ch. Glaz
Anumber of respiratory infections can result in pulmonary fibrosis as an outcome. SARS-CoV2, along with other coronaviruses, is no exception. The factors contributing to the formation of fibrosis are insufficiently studied. Nor are the methods for determining the activity of the process and the degree of fibrosis in the lung are well developed. Among the instrumental methods, along with computed tomography of the chest, an alternative option for dynamic monitoring can be the method of ultrasound examination of the lungs. Among laboratory parameters, C-reactive protein and fibrinogen are of interest.


Dyslipidemia in liver transplant recipients
E. Grigorenko, A. Shalimova, O. Rummo, N. Mitkovskaya
Liver transplant is known to be the only radical treatment for patients with end-stage liver diseases. It is known that cardiovascular diseases rank third among patients, who underwent liver transplant. Due to the current generally accepted policy of aggressive treatment of hypercholesterolemia, mortality from cardiovascular diseases has been significantly reduced in general population. Statin therapy has also demonstrated a decreasing effect on mortality among patients with chronic liver failure. Recently published research results have shown the increasing occurrence of non-communicable diseases among liver recipients, including diseases that determine cardiovascular mortality (arterial hypertension, chronic coronary syndrome, chronic heart failure, chronic kidney failure). This evidence demonstrates that in post-operative period doctors should do their best to identify not only traditional risk factors of acute transplant rejection, but also pay attention to cardiovascular risks and their timely treatment. Based on the data about a number of differences in the incidence of cardiovascular risk factors and on the specifics of confirmation and treatment of chronic coronary heart disease in liver transplant recipients in comparison with the general population, we believe that in transplant centers it is necessary to develop a specialized algorithm of dispensary follow-up of recipients (checklist) for adequate prevention of diseases of the circulatory system.
Angina without obstructive lesion coronary arteries (part 1). Pathophysiological aspects of development
S.Р. Solovey
Angina pectoris is one of the most common symptoms of ischemic heart disease (IHD). Coronary angiography in a significant part of patients with angina pectoris and signs of myocardial ischemia does not reveal obstructive atherosclerotic changes in the coronary arteries. Independent or additional mechanisms of ischemia can be microvascular dysfunction and epicardial coronary vasospasm. The clinical form of ischemic heart disease, which is based on ischemia caused by dysfunction of the coronary vessels in the absence of obstructive changes, has recently received the definition of INOCA (Ischaemia with No Obstructive Coronary Artery Disease). The concept of INOCA comprises two types of angina pectoris – microvascular and vasospastic. The underlying INOCA coronary vasomotor disorders have both different pathophysiological mechanisms and localization in the vascular system of the coronary circulation itself. Clinically the most important vasomotor disorders are epicardial and microvascular vasospasm, impaired microvascular vasodilation. The article provides a brief overview of the mechanisms of regulation of coronary blood flow under physiological conditions and vascular dysfunction in non-obstructive atherosclerotic lesions.
Ascending aorta wrapping in surgical correction of aortic valve disease
D. Bozhko
Objective: To study the results of surgical treatment of patients with ascending aorta dilatation and aortic valve disease. Methods: Echocardiographic examination was performed in all patients before surgery, within 1 month after surgery, and in the long-term period - once a year. Computed tomography was performed in patients from the main group as a control research method within 1 month after surgery and in the long-term period – once a year. Results: The results of surgical treatment of 255 patients with aortic valve disease and ascending aorta dilatation from 40 to 55 mm in the early postoperative and long-term periods with an average follow-up period of 3 years were analyzed. The wrapping method of the ascending aorta, performed in 93 patients, led to a significant decrease in the ascending aorta diameter from 45.47±2.96 mm to 35.98±3.88 mm, preventing the progression of its dilatation and aneurysm formation. The method showed a lower risk of complications in the early postoperative period compared to ascending aorta replacement. In the long-term follow-up, the frequency of major cardiovascular events and overall survival after aorta wrapping and aorta replacement in combination with correction of the aortic valve pathology did not differ significantly. After aorta wrapping, according to computed tomography, during the observation period, there were no complications from the ascending aorta in the form of dissection, intimal defects, wrap dislocation, aorta kinking; there was no significant calcification of the xenopericardial wrap. Conclusion: Ascending aorta wrapping can be performed as an alternative method of surgical treatment of the ascending aorta dilatation in aortic valve surgery in a certain cohort of patients with good results in the early postoperative and long-term follow-up periods.
Clinical significance of determining the lipocalin associated with neutrophil gelatinase urine levels in patients with st-elevation myocardial infarction and acute ischemic kidney injury
E. Brankovskaya, Е. Grigorenko, T. Statkevich, L. Kartun, E. Hodosovskaya, N. Mitkovskaya
The aim of the study was to assess the clinical significance of determining the level of lipocalin associated with neutrophil gelatinase in urine (uNGAL) at the time of hospital admission in patients with acute ST-elevation myocardial infarction (STEMI) and acute ischemic kidney injury. Conclusion. Acute ischemic kidney injury is a frequent complication of STEMI. Based on the findings of the study uNGAL can be applied as an early marker of acute ischemic kidney injury and a predictor of post-discharge CKD in patients with MI.


The role of endocardial catheter ablation in the management of paroxysmal ventricular tachycardia in patient with arrhythmogenic cardiomyopathy
D. Goncharik, L. Plashchinskaya, V. Barsukevich, A. Chasnoit, Ye. Rebeko, M. Zakharevsky, O. Kovalenko
The article describes current approaches to the interventional treatment of patients with arrhythmogenic cardiomyopathy (ACM) complicated with paroxysmal sustained ventricular tachycardia (VT). The advantages and disadvantages of two competing methods for mapping and ablation – activation mapping vs substrate mapping – are analyzed. The rationale for the proposed method of VT substrate mapping in ACM and the authors’ own results are presented. The results obtained by the authors make it possible to recommend substrate ablation according to the proposed technique as an invasive first-line therapy for patients with persistent monomorphic VT and ACM.
Cardiac resynchronization therapy in chronic heart failure with atrial fibrillation: analysis and result prediction
A. Kurlianskaya
Aim. To develop a multifactor response prediction model to CRT in patients with CHF complicated by AF taking into consideration myocardium dyssinchrony parameters, clinical, functional, and laboratory predictors of a positive response to interventional treatment. The linear model developed to assess the dynamics of LV ESV allows individualizing the patient selection for interventional treatment in case of predicting an unstable early response to CRT.
Dynamics of high residual platelet reactivity in patients with myocardial infarction in thrombolytic therapy
T. Pronko, V. Snezhitskiy, A. Kapytski
The aim of the study was to assess the incidence of high residual platelet reactivity in patients with myocardial infarction (MI), depending on the age and reperfusion therapy at different times from the onset of MI. Conclusion. The study revealed a high percentage of patients with MI with an insufficient response to acetylsalicylic acid and clopidogrel at different times from the onset of MI. There were no differences in the indicators of the aggregatogram depending on the age of the patients. There were no differences in the indicators of the aggregatogram depending on the type of reperfusion therapy performed (only TLT or TLT + PCI). There were no differences in the indicators of the aggregatogram depending on the type of implanted stents.
The results of heart transplantation depending on the severity of the left ventricular myocardial hypertrophy of the donor heart
S.V. Spiridonov, D.S. Tretyakov, P.E. Bulavskaya, A.V. Valentyukevich, T.A. Dubovik, N.V. Mankevich, Yu.P. Ostrovsky
The article discusses the impact of donor left ventricular (LV) hypertrophy on the survival of recipients after heart transplantation.
The association of the MTNR1B and the СYP1А1 gеnе pоlymоrphisms with the lеvеl оf melatonin and the risk оf оbstruсtivе slееp аpnеа/hypоpnеа syndrome development
V.I. Shyshkо, А.А. Kаrpоviсh, V.А. Snеzhitskiy, I.А. Kurstаk
The article discusses the prevalence of polymorphic variants of the MTNR1B gene and the C6310T locus of the CYP1A1 gene in patients with obstructive sleep apnea syndrome (OSAS) and analyzes their association with melatonin levels and the risk of developing OSAS.
Morphological changes in tissues during application bipolar coagulation and neodimate laser in gynecology
K. Agabekov, O. Lоbachevskaya, O. Yudina
The article is devoted to a comparative analysis of morphological changes in the tissues of the reproductive system of women under the influence of a neodymium laser and bipolar coagulation during laparoscopic operations. The results of assessing the reliability of dif ferences in morphometric indicators of tissue damage (sections of the fallopian tubes, fragments of ovarian tissue, membranes of benign cystic formations of the ovaries, leiomyomatous nodes of the body of the uterus) under the influence of electromagnetic radiation of various wavelengths are presented. The recorded changes directly depend both on the applied heat or light energy, and on the histological structure of the tissue under study. Fundamental differences in artifactual changes in tissues of the reproductive system were revealed when using bipolar coagulation and laser radiation in surgical practice, and the dependence of morphological changes on the wavelength of a neodymium laser was established for the first time.
A contemporary outlook on the potentialities of microcirculatory bed evaluation and methods for correcting disorders
A. Birulya
Investigation of the microcirculatory bed (MVB) has induced heightened interest both theoretical and practical in the medical world of the XX–XXI century. Evaluation of the MVB state has been widely used for revealing pathogenesis and developing an efficient treatment plan in cardiology, diabetology, oncology, dermatovenereology, dentistry, surgery, nephrology, urology, resuscitation and other branches of medicine. It’s worth noticing that evaluation of the microcirculatory parameters should be included into COVID-19 management for optimal medication of the patients especially in severe cases. The ar ticle provides a description of the microcirculator y bed, its structure, functions, mechanisms of regulation, causes of damage, and methods for diagnosing disorders. Proper consideration is given to the current techniques used to improve microcirculatory readings. Non-invasive techniques applied in the Republic of Belarus for improving the microcirculatory readings include the method of enhanced external counterpulsation and gravity therapy.
Anatomy of scrotal vessels and their pathological changes as the basis of clinical manifestations of varicocele
M. Doronin, I. Dub, S. Stoma, A. Beizerov
Varicocele is found in 8–40% of young men between the ages of 15 and 40. In 25.4% of cases, it is combined with a violation of reproductive function and in 40% of cases it causes pain syndrome in the scrotum. The etiology and pathogenesis of the disease are associated with various disorders in venous hemodynamics of the upstream vascular network. The peculiarity of venous blood outflow from the organs of the scrotum is the presence of a developed network of anastomoses and collaterals at the level of the scrotum, the inguinal region and the retroperitoneal space.
Surgical treatment of varicocele: shunting, occlusive and endovascular interventions
I. Dub, M. Doronin, S. Stoma, R. Kurlenko
The frequency of recurrence after surgical treatment of varicocele reaches 29%. This circumstance encourages the medical community to search for the optimal surgical aid to prevent pathological reflux of blood into the venous plexuses of the testicle from the overlying parts of the vascular network. The operation is indicated in case of presence of the clinical symptoms, the development of orchopathy and disorders of spermatogenesis, regardless of the degree of development of varicocele (WHO classification 2010). Operations aimed at eliminating varicocele are divided into 2 large groups: the first group – preserving the renocaval shunt or shunting operations and the second group – not preserving the renocaval shunt or occlusive operations. Shunting operations include the creation of intervenous anastomoses: proximal, distal and bidirectional. Proximal anastomoses are aimed at eliminating renal venous hypertension as the direct cause of the disease. The imposition of bidirectional and distal anastomoses is considered inappropriate, since in the first case, the time of surgical intervention increases, and in the second case, renal hypertension is not eliminated. Occlusive operations are indicated for primary varicocele and the absence of pronounced venous hypertension. According to the level of vein ligation, they are divided into supra-inguinal and sub-inguinal, by selectivity into selective and non-selective, and by operative access into open, laparoscopic and endovascular. The lowest number of relapses and postoperative complications is observed in sub-inguinal selective and endovascular techniques. They are the most universal ones and eliminate all hemodynamic types of varicocele. Supra-inguinal selective techniques show their high effectiveness in the renospermatic type of varicocele and, unlike sub-inguinal operations, there is no risk of damage to the testicular artery during the operation. Thus, a differentiated approach to choosing the type of surgery reduces the risk of postoperative complications and prevents recurrence of the disease.
Cardiac magnetic resonance imagining in viral myocarditis in patients with COVID-19: unsolved problems
T. Ilyina, A. Pleshko, T. Korotkaya, N. Mitkovskaya
Cardiac manifestations in COVID-19, including myocardial injury with elevated troponin levels, are common. Myocarditis has been reported as a possible complication in coronavirus patients, but direct evidence for SARS-CoV-2 myocarditis remains limited. The described series of histopathological confirmations of myocarditis in COVID-19 differ in severity and interpretation. Clinical manifestations of non-ischemic myocardial injury are nonspecific, differential diagnosis is even more difficult due to the complications after viral pneumonia. Cardiac Magnetic Resonance Imaging (CMRI) is a powerful tool for studying structural and functional changes in myocardial injury. New pulse sequences of parametric mapping with determination of the T1 and T2 relaxation times of the myocardium are a unique method for quantitative assessment of the myocardium tissue. Within 6 months in 2021, we retrospectively analyzed the CMRI results of 45 patients with COVID-19 at the Republican Scientific and Practical Center “Cardiology”. The percentage of patients with positive criteria for Lake Louise myocarditis was 18% (n = 8). The elevated reference values of T2 ≥ 2σ up to 33% was the most frequent pathological change in myocardial tissue characteristics. There is significant variability in the published data collection as to the prevalence of myocarditis associated with different research methodologies in studies and discrepancies in the interpretation of MRI-mapping data. This brief review is aimed at revising and summarizing current knowledge on myocarditis in COVID-19 patients and highlight the problems of CMRI diagnostics.
An elderly patient with acute coronary syndrome: management during COVID-19 pandemic
N.L. Tsapaeva, Е.B. Petrova, A.A. Pleshko
An increased number of elderly people in the medical terms means the predominance of pathology in the morbidity structure, which is determined by comorbidity, systemic lesions and an unfavorable prognosis. Comorbid patients are the most vulnerable group with a particularly high risk of adverse outcomes. In the presented review, the problem of management of acute coronary syndrome (ACS) in elderly patients in the context of the COVID-19 pandemic is addressed. The review demonstrates results of randomized clinical trials and registries of recent years, which purposefully included patients with ACS aged ≥ 75 years. Particular attention is paid to the need for a geriatric assessment of patients, the presence and severity of senile asthenia and its influence on the choice of treatment tactics and prognosis. The problem of choosing a method of myocardial revascularization and drug therapy schemes in elderly patients is considered under pandemic conditions. Issues related to drug interactions between drugs for the treatment of acute forms of coronary heart disease and drugs for the treatment of COVID-19 are reflected. In this situation, taking into account the risks of possible drug-drug interactions is of particular importance, which is especially challenging in elderly comorbid patients. Based on the available data, we have analyzed the main trends in the choice of treatment tactics for elderly patients with ACS during the COVID-19 pandemic.
Rheumatoid arthritis and heart disease – is it really relevant?
Andrey P. Rebrov
The article presents data on clinically significant heart impairment in patients with rheumatoid arthritis (RA), as well as features of the development of ischemic and non-ischemic heart disease with a significant increase in the risk of adverse cardiovascular events. Patients with RA are characterized by an increased risk of developing myocardial infarction, heart failure, rhythm disturbances, sudden cardiac death, and general cardiovascular death. The paper emphasizes the possibility of a fairly rapid development of myocardial dysfunction in patients with RA from the moment of manifestation of the disease, the development and progression of atherosclerosis of the coronary arteries. Besides, in case of the development of a coronary artery disease in RA patients, the worst survival rate after a heart attack was established. The available findings suggest that rheumatoid arthritis is a disease that makes a significant contribution to cardiovascular morbidity and mortality.

Guidelines for Authors

The requirements for submitting scientific articles are based on the 'Unified Requirements for Manuscripts Submitted to Biomedical Journals' of the International Committee of Medical Journal Editors (the official version is available on the website www.ICMJE.org).

Submission of an article implies that the work described has not been previously published or already accepted for publication in other journals. The articles are published in Belarusian, Russian, and English. The articles which do not meet the 'Rules and Norms of Humane Treatment of Biological Objects of Research' are not accepted for publication. All articles submitted to the editorial office undergo multi-stage peer review, including verification by “Anti-plagiarism” system of automatic text checking for borrowings from the publicly available information sources. Comments of reviewers are sent to the author without specifying the names of reviewers. After receiving the reviews and the author’s reply, the editorial board makes a decision on publication (or rejection) of the article. The editors reserve the right to reject the article without stating reasons. The order and sequence of an article publication is determined depending on the volume of published materials and the list of sections in a particular issue. Minor corrections of stylistic, nomenclature and formal character are made without the author’s consent. If the article was processed by the author in the process of preparation for publication, the date of receipt is considered to be the day of the final text submission.

The Editorial Board of the journal 'Emergency Cardiology and Cardiovascular Risks' accepts the following types of articles:

1) original scientific materials and research data;
2) scientific reviews.

The electronic version of the article should be typed in Microsoft Word and printed on one side of the paper, Times New Roman font, 12. The font color is black. size 14 and 1,5 spaced in two copies. The width of the left margin is 3 cm, top and bottom – 2,5 cm, right – 1 cm. Portrait orientation. No hyphenation. Formatting is made in the 'width' parameter. Headings and subheadings are typed in bold with alignment to the left; no dot is placed at the end of the heading. No other text formatting is allowed in the article. One paragraph indent is left before the headings.

1 Article Structure

1.1 Article Description (in Russian)

1.1.1 UDC (Universal Decimal Classification) code

1.1.2 Initials and surnames of the author(s)

1.1.3 Title of the article

1.1.4 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.1.5 Abstract in Russian (the volume for original research should be from 1800 to 2500 characters with spaces; and at least 1000 characters for review articles and descriptions of clinical cases). Original scientific research articles require structured abstracts: the purpose, methods, main results and conclusions of the work.

1.1.6 Keywords

1.2 Article Description (in English)

1.2.1 Initials and surnames of the author(s) (should correspond to the passport or be transliterated in the BSI system (British Standard Institute; UK, http://translit.ru/)

1.2.2 Title of the article

1.2.3 Official name of the organization where the authors work (superscript Arabic numerals indicate the institution)

1.2.4 Abstract in English (the volume for original research should be from 1800 to 2500 characters with spaces and at least 1000 characters for review articles and descriptions of clinical cases). The abstract is a brief summary of a research article and may be published as a separate entity.

The abstract must outline the most important aspects of the study. Abstracts should have a structured format (for original scientific articles: purpose, methods, results and conclusions). However, the subject, topic, purpose, method of research are given if they are new or of special interest. The text of the abstract should be clear and concise without any secondary information, general statements or complicated grammar structures.

References to the literature and abbreviations (except standard ones) are not allowed.

The results are stated precisely. The main theoretical and experimental findings, actual data, discovered relationships and patterns are given. Special emphasis should be placed on the new findings and the data having potential practical implication. 

The conclusions can be accompanied by recommendations, evaluations, suggestions, hypotheses, described in the article.

The abstract in English should not be a mere translation of the Russian version.

1.2.5 Keywords (according to MeSH).

2 Article Body

Depending on the type of the manuscript, the structure of the full text may be different.

The volume of original research and clinical cases descriptions, including figures, tables, literature index and summary should not exceed 30 thousand characters with spaces and that of reviews and lectures - 45 thousand characters with spaces.

Abbreviations are not allowed to be used, except for the chemical and common abbreviations, mathematical values, measurements and terms. The author of the article is to use the International System of Units (SI).

2.1 Original scientific articles

Original scientific articles contain the results of original research.

Sections of Original Scientific Article:

  • Introduction (not exceeding 2 pages) should state the topicality of the problem, including its significance (prevalence, morbidity, etc.) as well as mediated effects (social, economic). The solved and unsolved aspects of the problem should be identified with the analysis of previously published data.
  • Purpose of research;
  • Methods (the section should contain information on the design of the study, its duration, the method for evaluating the results, testing the hypothesis with describing the statistical methods and processing the results);
  • Results (description of the research content and main findings in detail; if necessary the section may be broken into subsections);
  • Discussion (the obtained results should be discussed from the point of view of novelty and compared with the known data);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the work);
  • Conflict of interests (presence of obvious and potential conflicts of interests, that is, conditions and facts that can influence the results of the research or their interpretation);
  • Expression of gratitude.

2.2 Scientific Review

The purpose of the review article should be a discussion of the accumulated material and the presentation of a new view of the author on previously described phenomena, a rethinking and search for new approaches to their interpretation, but not just listing the facts and stating the current state of the problem.

Sections of Scientific Reviews:

  • Introduction;
  • Discussion (may be presented as a separate section or run systematically through the text);
  • Conclusion (should be presented in the form of a complete text);
  • Source of financing (specify the source of funding for the analytical work);
  • Conflict of interests (presence of conflicts of interests, i.e. conditions and facts that can affect the results of the research or their interpretation);
  • Expression of gratitude.

3 References

Bibliographic index is placed at the end of the original article and should not contain more than 25 sources cited by the author. For scientific reviews it may be of no more than 50 sources in order of mention. In the text the author makes reference to the serial Index number in square brackets. Bibliographical description of the cited references should be in accordance with the requirements of the Higher Attestation Commission of the Republic of Belarus.

According to the requirements of international systems of citation the authors of the articles have to present references in the original language and in Latin alphabet. English references are identical to the ones transliterated to Latin alphabet.

4 Author information

The following elements must be included:

  • full names of all authors, their academic titles and degrees
  • postal address of the institution, the e-mail of each author and phone numbers

5 Tables

All the tables should be titled, numbered and self-explanatory. The data presented in tables should correspond to the numbers in the text but not duplicate results described elsewhere in the article. References to tables in the text are required. The titles of the tables and descriptions should be duplicated in English.

6 Illustrations

The quantity of graphics should be minimal.  Each illustration should have numbered picture captions. References to illustrations are required.  The titles of the figures and diagrams and their descriptions should be also duplicated in English. Links to figures in the text are required.

Illustrations (graphs, charts, drawings) performed in MS Office format should be contrast and clear. Illustrations should be performed in a separate file in*.jpeg, *.bmp, *.gif formats and placed in the article as fixed images. Do not use MS WORD to apply any elements on top of the inserted image (arrows, captions) due to the high risk of missing symbols during the editing and page make-up stages.

Photos, screenshots and other images should be embedded in the main text and also provided as separate files in *.jpeg, *.bmp, *.gif formats (*.doc and *.docx – in case of additional marks). The resolution of photographic images should be >300 dpi.

Each file should be titled and correspond to the image number in the text. In the file description picture captions should be placed and correspond to the name of the image embedded in the text.

The article should be submitted to the editor in the electronic version with the signatures of the authors. The article must be accompanied by a Letter of Application written in a free form.

Submission of an article for publication to 'Emergency Cardiology and Cardiovascular Risks' journal implies the consent of the author (s) with the published rules.

Address for letters
E-mail: emcardio@bsmu.by  

The order of reviewing article manuscripts submitted to the scientific and practical peer-reviewed journal “Emergency Cardiology and Cardiovascular Risks”

Manuscripts of all scientific articles submitted to the editors are subject to mandatory review by two independent experts. Review is carried out by the scientists who are recognized experts in the field of reviewed materials and work in the field of knowledge to which the content of the manuscript belongs and who have had publications on the subject of the article under review over the last three years.

The author, supervisor of a scientific degree scholar or coauthors of the reviewed work cannot be reviewers. The review of a scientific article is issued in accordance with the Memo to the reviewer of scientific articles and materials submitted to the journal “Emergency Cardiology and Cardiovascular Risks”.

Manuscripts are not considered for publication in case they do not meet the “Rules for Authors” which are published for convenience in the journal and its electronic version.

The editor informs the author about the review result by providing a copy of the review. The review contains recommendations for publication, correction and improvement of the article or a reasonable refusal. The author of the manuscript may take into account the recommendations when preparing a new version of the article or reasonably refute them. Articles refined by the author are resubmitted for review by a reviewer who made critical comments. The incoming date is considered to be the date of the refined article submission. If the author disagrees with the reviewer's comments, he may apply for a second review engaging a third expert or withdraw the article.

Articles and article reviews are discussed at the meeting of the editorial board, which serves as a basis to accept or reject an article. The decision of the editorial board is registered in by the protocol.

The order and priority of publications are determined depending on the volume of published materials and the list of subdivisions in a particular issue.

The editorial board does not guarantee the publication of all submitted materials. The article will not be accepted for consideration if it has been published or sent to other journals, the authors have not provided their complete personal data or the article does not meet the “Rules for Authors”. The editors reserve the right to edit the article without notifying the authors.

The final decision on the expediency of publications after their reviewing is made by the editorial board.

Articles not allowed for publication:

  • manuscripts which are not related to the scientific area of the journal;
  • manuscripts which do not meet the design requirements and their authors refuse to make their technical refinement;
  • manuscripts, the authors of which did not change the article according to the constructive requirements of the reviewer;

manuscripts, representing significant plagiarism due to copying data or conclusions from another author’s research without proper citation/reference (according to the recommendations of the World Association of Medical Editors (WAME) and COPE (Committee on Publication Ethics)); resubmission of the publication under the name of another author (in the original language or in translation); verbatim copying of more than 100 words from another (including his own) publication in the absence of a properly arranged quotation; unpublished borrowings of previously published ideas or hypotheses of other authors, and/or those that have not been tested by the “Anti-plagiarism” Automatic Text Checking System for borrowing from publicly available information sources.

If plagiarism is suspected:

the editorial board informs the experts and the author(s) of the material in writing about the initiation of the editorial investigation and its expected timeframe (2 months). Based on the results of the editorial investigation, a written statement is drawn up (stored in the editorial office), copies of which are provided to the person who discovered the fact of plagiarism and the author(s) about the decision made and the undertaken actions.

In case of insignificant plagiarism the editors of the journal must notify the author about the fact of plagiarism and obtain written explanations. If a violation by the author is qualified as unintentional, confine to a reprimand and sending a message about the inappropriateness of repeated cases. A revised manuscript with references to all original sources of borrowing may be published.

Manuscripts and electronic versions of both published and unpublished materials are not returned.

Reviews are kept in the editorial office for five years.

About Us

ISSN 2616-633X

Publishing semi-annual
Articles in Russian. Summaries in English

Address:

Dzerzhinski Ave., 83, Minsk, Republic of Belarus, 220116
Tel: +375 17 277-12-01.
Fax: +375 17 277-12-02
E-mail:  emcardio@bsmu.by
Web-site:  https://emcardio.bsmu.by

Editor-in-chief: Prof. Natalya P. Mitkovskaya, MD, PhD. Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Secretary: Ekaterina B. Petrova, PhD Educational Institution «Belarusian State Medical University», Minsk, Belarus

Executive Editorial Office Secretary: Olga V. Laskina. Educational Institution «Belarusian State Medical University», Minsk, Belarus

 

Editor-in-chief greeting

 

Publication Ethics

Editorial Board

Sikorskij A.V., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Vojtovich T.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Gelis L.G., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Gubkin S.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Danilova L.I., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Dzjadz`ko A.M., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Karpov I.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kirkovkij V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kozlovkij V.i., Grand PhD in Medical sciences, Professor (Vitebsk, Belarus)
Kopitov A.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ostrovskij Ju.P. A.Yu., PhD in Medical sciences, Associate Professor  (Minsk, Belarus)
Petrova M.N., PhD in Philological sciences, Associate Professor  (Minsk, Belarus)
Pristrom A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenko E.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Rudenok V.V., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Ruzanov D.Yu., PhD in Medical sciences, Associate Professor (Gomel, Belarus)
Salivonchik D.P., Grand PhD in Medical sciences, Professor (Gomel, Belarus)
Sidorovich E. K., Grand PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Sudzhaeva O.A., Grand PhD in Medical sciences (Minsk, Belarus)
Uss A.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tsapaeva N.L., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Yanushko A.V., PhD in Medical sciences, Associate Professor (Grodno, Belarus)

 

Advisory Editorial Board

(International Consultative Committee)

Abel`skaya I.S., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Khryshchanovich V.Ya., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Azimferey Leonhard, Grand PhD in Medical sciences, Professor (Tîrgu Mureș, Romania)
Arutjunov G.P., Corresponding Member of the Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Bedel'baeva G.G., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Beljaeva L.N., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Vismont F.I., Corresponding Member of the National Academy of Sciences o Belarus , Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Dzhunusbekova G.A., Grand PhD in Medical sciences, Professor (Almaty, Kazakhstan)
Drapkina O.M., Corresponding Member of Russian Academy of Sciences , Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Dudarenko S.V., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Kamilova U.K., Grand PhD in Medical sciences, Professor (Tashkent, Uzbekistan)
Kibira Satoshi, Grand PhD in Medical sciences, Professor (Akita, Japan)
Koziolova N.A., Grand PhD in Medical sciences, Professor (Perm, Russian Federation)
Kostjuk William, Grand PhD in Medical sciences, Professor (London, Canada)
Krasnyj S.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kubarko A.I., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Kul'chickij V.A., Corresponding Member of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Linn Tommi, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Mrochek A.G., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Oganov R.G., Academician of the Russian Academy of Sciences,  Grand PhD in Medical sciences, Professor (Moscow, Russian Federation)
Ostrovskij Ju.P., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Pershagen Joran, Grand PhD in Medical sciences, Professor (Stockholm, Sweden)
Pinevich D.L., First Deputy Minister of Health of the Republic of Belarus (Minsk, Belarus)
Rebrov A.P., Grand PhD in Medical sciences, Professor (Saratov, Russian Federation)
Rud Charls, Grand PhD in Medical sciences, Professor (Berkeley, USA)
Rummo O.O., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Skugarevskij O.A., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Snezhickij V.A., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Grodno, Belarus)
Sukalo A.V., Academician of the National Academy of Sciences of Belarus,  Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Tiffi Patrik, Grand PhD in Medical sciences, Professor (London, Canada)
Tret'jak S.I., Corresponding Member of the National Academy of Sciences of Belarus, Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Fedoruk A.M., Grand PhD in Medical sciences, Professor (Minsk, Belarus)
Hirmanov V.N., Grand PhD in Medical sciences, Professor (St. Petersburg, Russian Federation)
Zhebentyayev A.I., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Gurina N.S., Grand PhD in Biological sciences, Professor (Minsk, Belarus)
Tsarenkov V.M., Grand PhD in Pharmaceutical Sciences, Professor (Minsk, Belarus)
Khishova O.M., Grand PhD in Pharmaceutical Sciences, Professor (Vitebsk, Belarus)
Kuznetsov V.A., Grand PhD in Medical sciences, Professor (Tyumen, Russian Federation)

 

Publishing Group

Balysh E. M., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Rachok L.V., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Volod'ko Ju.S., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Gerasimenok D.S., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Grigorenko E.A., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Mazanik Ju.N., (Minsk, Belarus)
Martusevich N.A., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Pyko A.A., PhD in Medical sciences (Minsk, Belarus)
Rustamov M.N., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Skakun L.N., (Minsk, Belarus)
Statkevich T.V., PhD in Medical sciences, Associate Professor (Minsk, Belarus)
Tenjushko E.S., (Minsk, Belarus)
Lanushevskaia A.V., (Minsk, Belarus)
Korzhenevskaia Iu.V., (Minsk, Belarus)
Tkachyova O.A., design, computer layout (Minsk, Belarus)
Vinokurov V.F., design, computer layout (Minsk, Belarus)
Zhuk L.I., editor (Minsk, Belarus)